We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Therapeutic Agent for Mustard Gas Injuries

By Biotechdaily staff writers
Posted on 17 Feb 2003
A post-injury agent for treating skin and eye injuries by mustard gas is being developed by Quick-Med Technologies, Inc. More...
(Gainesville, FL, USA) in collaboration with the US Army.

Mustard gas, also called sulfur mustard, is one of the oldest chemical weapons. Threat assessment by the US Army considers sulfur mustard the most likely agent to be used by terrorists or foreign governments due to its low cost to produce, store, and dispense. Quick-Med has completed phase I and phase II clinical safety data studies for related ocular conditions and expects to acquire that data soon, as well as formulation analyses for the skin and eyes, and the results of efficacy experiments being conducted in laboratories in Israel and The Netherlands. The compound being used by Quick-Med is called Ilomastat.

"Quick-Med has an excellent opportunity to provide an important new drug to military and civil defense organizations worldwide. It will fill a major void in our preparedness against chemical and biologic attacks,” said Major General George Friel, a director of Quick-Med, who formerly headed the Nuclear, Chemical, and Biologic Defense Command for the US Army.





Related Links:
Quick-Med

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.